AARTIPHARM vs ORTINGLOBE: Stock Comparison

Aarti Pharmalabs Limited vs ORTIN GLOBAL LIMITED

Live data: 22 July 2026, 2:59 PM IST • Source: NSE and company filings

Aarti Pharmalabs Limited is the larger company by market capitalisation. Aarti Pharmalabs Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Aarti Pharmalabs Limited and ORTIN GLOBAL LIMITED on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AARTIPHARM is more favourable on 8 of 10 scored metrics and ORTINGLOBE on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
AARTIPHARM is the larger company
₹6,253 Cr vs ₹12 Cr
EPS
AARTIPHARM has higher earnings per share
₹19.26 vs ₹-1.13
Dividend Yield
AARTIPHARM has a higher dividend yield
0.57% vs 0%
Revenue Growth (TTM YoY)
AARTIPHARM has faster revenue growth
3.3% vs -76.86%
EPS Growth (TTM YoY)
ORTINGLOBE has faster EPS growth
0% vs -30.8%
Qtr Sales Growth
AARTIPHARM has stronger quarterly sales growth
3.35% vs 0%
Qtr Profit Growth
ORTINGLOBE has stronger quarterly profit growth
0% vs -30.8%
ROE
AARTIPHARM has a higher ROE
8.59% vs -59.85%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAARTIPHARMORTINGLOBE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAARTIPHARMORTINGLOBE
Live Price₹676.65₹18.02
Day Change-3.66%0.5%
Volume1.65 L48,801
52-Week High₹969.5₹21.3
52-Week Low₹585₹10.86
Distance from 52W High-30.21%-15.4%

Valuation

MetricAARTIPHARMORTINGLOBE
Market Cap₹6,253 Cr₹12 Cr
P/E Ratio36.57x
P/B Ratio3.01x
EPS₹19.26₹-1.13
Book Value₹234.28₹2.43
Dividend Yield0.57%0%

Growth

MetricAARTIPHARMORTINGLOBE
Revenue Growth (TTM YoY)3.3%-76.86%
EPS Growth (TTM YoY)-30.8%0%
Qtr Sales Growth3.35%0%
Qtr Profit Growth-30.8%0%

Profitability & Leverage

MetricAARTIPHARMORTINGLOBE
ROE8.59%-59.85%
ROCE10.7%0%
Net Margin10.25%-529.87%
Operating Margin20.3%
Debt to Equity0.36x0.81x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAARTIPHARMORTINGLOBE
Promoter Holding42.69% 0.22 pp1.23%
FII Holding8.17% 0.22 pp1.68%
DII Holding7.22% 0.19 pp0%
Public Holding41.74% 0.63 pp97.09%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Aarti Pharmalabs Limited and ORTIN GLOBAL LIMITED.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.